Literature DB >> 9671778

A phage display approach for rapid antibody humanization: designed combinatorial V gene libraries.

C Rader1, D A Cheresh, C F Barbas.   

Abstract

The development of a new strategy for antibody humanization is described. This strategy incorporates key recognition sequences from the parental rodent antibody into a phage display-based selection strategy. The original sequences of the third complementarity-determining regions (CDRs) of heavy and light chains, HCDR3 and LCDR3, were maintained and all other sequences were replaced by human sequences selected from phage-displayed antibody libraries. This approach was applied to the humanization of mouse mAb LM609 that is directed to human integrin alphav beta3 and has potential applicability in cancer therapy as an antiangiogenic agent. We demonstrate this approach (i) provides a rapid route for antibody humanization constraining the content of original mouse sequences in the final antibodies to the most hypervariable of the CDRs; (ii) generates several humanized versions with different sequences at the same time; (iii) results in affinities as high as or higher than the affinity of the original antibody; and (iv) retains the antigen and epitope specificity of the original antibody. The production of multiple humanized variants may present advantages in the selection of antibodies that are more readily expressed on a large scale and could be important in therapeutic regimens that call for long-term treatment with antibodies in which antiidiotypic responses might be avoided by administration of alternative antibodies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9671778      PMCID: PMC21176          DOI: 10.1073/pnas.95.15.8910

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  The repertoire of human germline VH sequences reveals about fifty groups of VH segments with different hypervariable loops.

Authors:  I M Tomlinson; G Walter; J D Marks; M B Llewelyn; G Winter
Journal:  J Mol Biol       Date:  1992-10-05       Impact factor: 5.469

2.  Antibody framework residues affecting the conformation of the hypervariable loops.

Authors:  J Foote; G Winter
Journal:  J Mol Biol       Date:  1992-03-20       Impact factor: 5.469

Review 3.  Integrins: versatility, modulation, and signaling in cell adhesion.

Authors:  R O Hynes
Journal:  Cell       Date:  1992-04-03       Impact factor: 41.582

4.  Antibody redesign by chain shuffling from random combinatorial immunoglobulin libraries.

Authors:  A S Kang; T M Jones; D R Burton
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

Review 5.  Synthetic human antibodies.

Authors:  C F Barbas
Journal:  Nat Med       Date:  1995-08       Impact factor: 53.440

6.  Expression studies of catalytic antibodies.

Authors:  H D Ulrich; P A Patten; P L Yang; F E Romesberg; P G Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

7.  Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda.

Authors:  W D Huse; L Sastry; S A Iverson; A S Kang; M Alting-Mees; D R Burton; S J Benkovic; R A Lerner
Journal:  Science       Date:  1989-12-08       Impact factor: 47.728

8.  Human combinatorial antibody libraries to hepatitis B surface antigen.

Authors:  S L Zebedee; C F Barbas; Y L Hom; R H Caothien; R Graff; J DeGraw; J Pyati; R LaPolla; D R Burton; R A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

9.  High level Escherichia coli expression and production of a bivalent humanized antibody fragment.

Authors:  P Carter; R F Kelley; M L Rodrigues; B Snedecor; M Covarrubias; M D Velligan; W L Wong; A M Rowland; C E Kotts; M E Carver
Journal:  Biotechnology (N Y)       Date:  1992-02

10.  Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library.

Authors:  T J Vaughan; A J Williams; K Pritchard; J K Osbourn; A R Pope; J C Earnshaw; J McCafferty; R A Hodits; J Wilton; K S Johnson
Journal:  Nat Biotechnol       Date:  1996-03       Impact factor: 54.908

View more
  17 in total

Review 1.  Molecular engineering of antibodies for therapeutic and diagnostic purposes.

Authors:  Frédéric Ducancel; Bruno H Muller
Journal:  MAbs       Date:  2012-07-01       Impact factor: 5.857

2.  Conversion of scFv peptide-binding specificity for crystal chaperone development.

Authors:  Jennifer C Pai; Jeffrey A Culver; Jason E Drury; Rakesh S Motani; Raquel L Lieberman; Jennifer A Maynard
Journal:  Protein Eng Des Sel       Date:  2011-01-08       Impact factor: 1.650

Review 3.  Mining human antibody repertoires.

Authors:  Roger R Beerli; Christoph Rader
Journal:  MAbs       Date:  2010-07-01       Impact factor: 5.857

4.  Augmented Binary Substitution: Single-pass CDR germ-lining and stabilization of therapeutic antibodies.

Authors:  Sue Townsend; Brian J Fennell; James R Apgar; Matthew Lambert; Barry McDonnell; Joanne Grant; Jason Wade; Edward Franklin; Niall Foy; Deirdre Ní Shúilleabháin; Conor Fields; Alfredo Darmanin-Sheehan; Amy King; Janet E Paulsen; Timothy P Hickling; Lioudmila Tchistiakova; Orla Cunningham; William J J Finlay
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-30       Impact factor: 11.205

5.  Integrin targeted therapeutics.

Authors:  Melissa Millard; Srinivas Odde; Nouri Neamati
Journal:  Theranostics       Date:  2011-02-17       Impact factor: 11.556

6.  Protein and Antibody Engineering by Phage Display.

Authors:  J C Frei; J R Lai
Journal:  Methods Enzymol       Date:  2016-06-29       Impact factor: 1.600

7.  The Therapeutic Antibody LM609 Selectively Inhibits Ligand Binding to Human αVβ3 Integrin via Steric Hindrance.

Authors:  Andrew J Borst; Zachary M James; William N Zagotta; Mark Ginsberg; Felix A Rey; Frank DiMaio; Marija Backovic; David Veesler
Journal:  Structure       Date:  2017-10-12       Impact factor: 5.006

8.  Production and characterization of a humanized single-chain antibody against human integrin alphav beta3 protein.

Authors:  Dabin Liu; Chen Wang; Cun Li; Xin Zhang; Baozhong Zhang; Zhiqiang Mi; Xiaoping An; Yigang Tong
Journal:  J Biol Chem       Date:  2011-05-23       Impact factor: 5.157

9.  Humanization of rabbit monoclonal antibodies via grafting combined Kabat/IMGT/Paratome complementarity-determining regions: Rationale and examples.

Authors:  Yi-Fan Zhang; Mitchell Ho
Journal:  MAbs       Date:  2017-02-06       Impact factor: 5.857

10.  Using antibody catalysis to study the outcome of multiple evolutionary trials of a chemical task.

Authors:  A Karlstrom; G Zhong; C Rader; N A Larsen; A Heine; R Fuller; B List; F Tanaka; I A Wilson; C F Barbas; R A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.